Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 323

1.

The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women.

Boone SD, Baumgartner KB, Joste NE, Pinkston CM, Yang D, Baumgartner RN.

Cancer Causes Control. 2014 Mar;25(3):273-82. doi: 10.1007/s10552-013-0329-3.

PMID:
24337810
2.

Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data.

Schinkel JK, Zahm SH, Jatoi I, McGlynn KA, Gallagher C, Schairer C, Shriver CD, Zhu K.

Cancer Causes Control. 2014 Aug;25(8):959-68. doi: 10.1007/s10552-014-0395-1.

PMID:
24839049
4.

Behavioral risk factors and their relationship to tumor characteristics in Hispanic and non-Hispanic white long-term breast cancer survivors.

Abdel-Maksoud MF, Risendal BC, Slattery ML, Giuliano AR, Baumgartner KB, Byers TE.

Breast Cancer Res Treat. 2012 Jan;131(1):169-76. doi: 10.1007/s10549-011-1705-x.

5.

Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.

Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA.

JAMA. 2015 Jan 13;313(2):165-73. doi: 10.1001/jama.2014.17322. Erratum in: JAMA. 2015 Jun 9;313(22):2287.

6.

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK.

J Natl Cancer Inst. 1994 May 4;86(9):705-12.

PMID:
7908990
7.

Disparities in the risk of the ER/PR/HER2 breast cancer subtypes among Asian Americans in California.

Parise C, Caggiano V.

Cancer Epidemiol. 2014 Oct;38(5):556-62. doi: 10.1016/j.canep.2014.08.001.

PMID:
25172158
8.

Breast cancer among Hispanic and non-Hispanic White women in Arizona.

Martínez ME, Nielson CM, Nagle R, Lopez AM, Kim C, Thompson P.

J Health Care Poor Underserved. 2007 Nov;18(4 Suppl):130-45.

PMID:
18065856
9.
10.

Obesity and risk of breast cancer mortality in Hispanic and Non-Hispanic white women: the New Mexico Women's Health Study.

Connor AE, Baumgartner RN, Pinkston C, Baumgartner KB.

J Womens Health (Larchmt). 2013 Apr;22(4):368-77. doi: 10.1089/jwh.2012.4191.

11.

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.

Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, Cronin KA.

J Natl Cancer Inst. 2014 Apr 28;106(5). pii: dju055. doi: 10.1093/jnci/dju055.

12.

Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.

Killelea BK, Yang VQ, Wang SY, Hayse B, Mougalian S, Horowitz NR, Chagpar AB, Pusztai L, Lannin DR.

J Clin Oncol. 2015 Dec 20;33(36):4267-76. doi: 10.1200/JCO.2015.63.7801.

PMID:
26598753
13.

Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.

Bae SY, Kim S, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Lee JE, Nam SJ.

BMC Cancer. 2015 Mar 18;15:138. doi: 10.1186/s12885-015-1121-4.

14.

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.

J Clin Oncol. 2015 Jul 10;33(20):2254-61. doi: 10.1200/JCO.2014.57.1349.

15.

Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.

Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R, Burkman RT, Strom BL, McDonald JA, Folger SG, Simon MS, Sullivan-Halley J, Press MF, Bernstein L.

BMC Cancer. 2013 May 4;13:225. doi: 10.1186/1471-2407-13-225.

16.

Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW.

Breast Cancer Res Treat. 2009 Jan;113(2):357-70. doi: 10.1007/s10549-008-9926-3.

PMID:
18324472
17.

Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women.

Wenten M, Gilliland FD, Baumgartner K, Samet JM.

Ann Epidemiol. 2002 Aug;12(6):435-4.

PMID:
12160603
18.

Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases.

Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP.

Cancer. 1996 Apr 15;77(8):1465-71.

19.

Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.

Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, Munsey B, Panella T, Orucevic A.

Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059.

PMID:
23240985
20.

Triple-negative breast cancers are increased in black women regardless of age or body mass index.

Stead LA, Lash TL, Sobieraj JE, Chi DD, Westrup JL, Charlot M, Blanchard RA, Lee JC, King TC, Rosenberg CL.

Breast Cancer Res. 2009;11(2):R18. doi: 10.1186/bcr2242.

Items per page

Supplemental Content

Support Center